Shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) have been given a consensus recommendation of “Hold” by the sixteen ratings firms that are presently covering the company. Four research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and nine have issued a buy recommendation on the company. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) net profit margin is -17.50% and weekly performance is -5.13%. On last trading day company shares ended up $20.14. Analysts mean target price for the company is $27.00. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) distance from 50-day simple moving average is -8.09%.
Shares of Perrigo Company PLC (NASDAQ:PRGO) have earned an average rating of “Buy” from the seventeen brokerages that are currently covering the stock. Three research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. Perrigo Company plc Ordinary Shares (NYSE:PRGO) shares advanced 1.92% in last trading session and ended the day on $153.31. PRGO Gross Margin is 35.70% and its return on assets is 9.20%. Perrigo Company plc Ordinary Shares (NYSE:PRGO) quarterly performance is -2.40%.
USANA Health Sciences (NASDAQ:USNA) Insider Dave Wentz sold 5,301 shares of USANA Health Sciences stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $75.51, for a total transaction of $400,278.51. Following the completion of the transaction, the insider now directly owns 473,955 shares of the company’s stock, valued at approximately $35,788,342. The sale was disclosed in a legal filing with the Securities & Exchange Commission. USANA Health Sciences, Inc. (NYSE:USNA) shares moved down -1.18% in last trading session and was closed at $78.83, while trading in range of $78.36-$79.46. USANA Health Sciences, Inc. (NYSE:USNA) year to date performance is 4.30%.
Natural Alternatives International, Inc. (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, on 13 may announced net income of $622,000 or $0.09 per diluted share on net sales of $19.1 million for the quarter ended March 31, 2014. Natural Alternatives International, Inc. (NASDAQ:NAII) ended the last trading day at $5.32. Company weekly volatility is calculated as 3.86% and price to cash ratio as 2.45. Natural Alternatives International, Inc. (NASDAQ:NAII) showed a negative weekly performance of -5.00%.
ProPhase Labs Inc (NASDAQ:PRPH) announced that on May 28, 2014, it has entered into a new Investment Agreement (the “Investment Agreement”) with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership (“Dutchess”). Pursuant to the Investment Agreement, Dutchess committed to purchase, subject to certain restrictions and conditions, up to 3,000,000 shares of the Company’s common stock, over a period of 36 months from the effectiveness of the registration statement registering the resale of shares purchased by Dutchess pursuant to the Investment Agreement. In connection with the Investment Agreement, the Company terminated its prior existing equity line of credit with Dutchess. ProPhase Labs Inc (NASDAQ:PRPH) net profit margin is -3.00% and weekly performance is 1.25%. On last trading day company shares ended up $1.62. Analysts mean target price for the company is $15.55. ProPhase Labs Inc (NASDAQ:PRPH) distance from 50-day simple moving average is -11.59%.
Leave a Reply